JFS Wealth Advisors’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.59K Buy
242
+28
+13% +$216 ﹤0.01% 1525
2026
Q1
$1.36K Buy
214
+13
+6% +$90 ﹤0.01% 1603
2025
Q4
$1.42K Buy
201
+104
+107% +$628 ﹤0.01% 1635
2025
Q3
$534 Buy
97
+74
+322% +$363 ﹤0.01% 1751
2025
Q2
$119 Sell
23
-155
-87% -$929 ﹤0.01% 1803
2025
Q1
$1.19K Sell
178
-8
-4% -$61 ﹤0.01% 1615
2024
Q4
$1.37K Buy
186
+175
+1,591% +$1.26K ﹤0.01% 1610
2024
Q3
$77 Buy
11
+3
+38% +$18 ﹤0.01% 1915
2024
Q2
$40 Hold
8
﹤0.01% 1965
2024
Q1
$50 Hold
8
﹤0.01% 1977
2023
Q4
$63 Sell
8
-55
-87% -$355 ﹤0.01% 1972
2023
Q3
$433 Buy
+63
New +$511 ﹤0.01% 1769

Other funds holding LFST

JFS Wealth Advisors's LFST Position: Q2 2026 in Review

JFS Wealth Advisors increased its Lifestance Health (LFST) stake by 13% in Q2 2026, buying an estimated $216 and bringing the position to 242 shares worth $2.59K. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

JFS Wealth Advisors first reported a position in LFST in Q3 2023 and has held it in 12 quarters since. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • JFS Wealth Advisors held 242 shares of Lifestance Health worth $2.59K as of Q2 2026.
  • JFS Wealth Advisors bought 28 Lifestance Health shares in Q2 2026, an estimated $216.
  • Lifestance Health made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1525 holding.
  • JFS Wealth Advisors first reported a position in Lifestance Health in Q3 2023 and has held it in 12 quarters since.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.